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ABSTRACT OF THE THESIS 
A Secondary Data Analysis of the Prevalence of Reported Dementia and Subjective Cognitive 
Decline Across U.S. National Surveys  
by 
Matthew C. Picchiello 
Master of Arts in Psychology 
Washington University in St. Louis, 2021 
Professor Brian Carpenter, Chair 
Within the United States, many large-scale, nationally representative studies exist with 
the goal of tracking and monitoring aspects of health. These studies are often used to establish 
the prevalence of dementia and subjective cognitive decline (SCD) in the population. The goal of 
the current study is to examine how different population-based studies probe respondents about 
conditions related to cognitive impairment, and to assess similarities and differences in point 
estimates. We reviewed eight studies and identified comparable items related to dementia and 
SCD. We calculated design-appropriate point prevalence estimates and compared weighted 
estimates across studies, finding a wide range and statistically significantly different estimates 
for dementia (estimates ranging from 2.7% - 9.9%) and for SCD (5.6% - 46.6%). Close analysis 
of item construction revealed meaningful differences in the use of terminologies and timeframes 
that could account for these differences. Moreover, subtle but consequential sampling differences 
were also discovered within study documentation that also could be responsible. Given the 
importance of prevalence estimates for research, practice, and policy, our findings highlight the 
need for harmonization across methodology in these large studies, even at their most basic level, 
to establish the true burden of these conditions.  
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 Dementia and subjective cognitive decline (SCD) are public health issues that affect 
many people in later life. Large-scale, nationally representative health surveillance projects, such 
as the Health and Retirement Study (HRS) and National Health and Nutrition Examination 
Survey (NHANES), are designed to track the prevalence of cognitive health in the American 
population, using a combination of objective assessments and self-reports (Clair et al., 2017). 
Yet prevalence estimates of cognitive impairment within the population vary considerably 
among these and similar studies (Brookmeyer et al., 2011; Prince et al., 2016). Previous research 
on the prevalence of other chronic conditions obtained within these national projects also 
found variability, which investigators attribute to the use of different disease definitions, 
items, and research methodologies (Fahimi et al., 2008; Hsia et al., 2020). No previous studies 
have specifically examined estimates regarding the prevalence of self-reported dementia and 
SCD across these nationally representative studies.  
There are a variety of reasons why it is important to understand the prevalence of a 
disease or condition. First, policy makers use estimates to identify public health priorities, which 
in turn influence workforce projections and the development of educational and training 
initiatives (Noordzji et al., 2010). Second, organizations such as the National Institutes of Health, 
the Centers for Disease Control, and the Alzheimer’s Association rely on prevalence estimates to 
show the burden of a disease on a given population, set research priorities, and allocate research 
funds (Anderson & Egge, 2014). Finally, at the level of clinical practice, prevalence estimates 
help clinicians understand the base rate of a condition among their patients, which can inform 
clinical decision making (Djulbegovic et al., 2014). For these reasons, obtaining reliable 
and valid prevalence estimates for dementia and SCD is imperative to establish the true burden 
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of these conditions in the population. Nonetheless, many nationally representative studies use 
different methods to establish the prevalence of dementia and SCD, which could lead to different 
estimates, with the implications outlined above for policy and practice.  
Methods to Obtain Prevalence Estimates  
Neuropsychological Testing  
The two most often cited and influential studies that establish dementia prevalence 
estimates make use of in-depth neuropsychological measures and clinical case consensus (Hebert 
et al., 2013; Plassman et al., 2007). Using a sample of adults age 65 or older in the Chicago area, 
Hebert and colleagues (2013) estimated 11.6% of adults reached diagnostic criteria for 
Alzheimer’s disease (AD) through NINCDS-ADRDA Work Group criteria. In comparison, a 
national study led by Plassman and colleagues (2007) using a subsample of the Health and 
Retirement Study (HRS) estimated that 13.9% of noninstitutionalized adults over the age of 70 
reached diagnostic criteria for a dementia diagnosis based on a comprehensive in-home 
assessment and criteria based on the DSM-III-R and DSM-IV. Prevalence estimates generated 
with standardized, objective assessments are arguably the most reliable and valid, yet even 
between these two much-cited studies prevalence estimates are different, perhaps due to the 
different age ranges across studies and the focus of Hebert and colleagues (2013) on AD cases 
only. Moreover, replications of these findings in other nationally representative samples have 
been lacking.   
Brief Cognitive Testing  
Other nationally representative studies conducted at a similar time have used simple 
cognitive tests to ascertain dementia prevalence. These studies often show much higher 
estimates. For example, using the AD8 within the nationally representative Panel Study of 
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Income Dynamics (PSID), Freedman and colleagues (2019) estimated that 21.9% of the 
population over the age of 65 screened positive for dementia. Similarly, high estimates were 
found within the National Social Health and Aging Project (NSHAP), which adapted the 
Montreal Cognitive Assessment and found that 25.8% of older adults screened positive for mild 
cognitive impairment and 15.3% for dementia (Kotwal et al., 2016). However, using the 
Telephone Interview for Cognitive Status within the HRS, Langa and colleagues (2017) 
estimated that 8.8% of older adults have dementia. As shown, the method of assessment can 
yield very different estimates.   
Moreover, one must use caution when interpreting estimates obtained with brief cognitive 
screening tests given that they may overestimate rates for individuals who have lower 
educational attainment or who are nonnative speakers (Skoog et al., 2017; Spering et al., 2012). 
Additionally, past research has found that estimates based on brief cognitive tests performed at a 
single interview may overestimate the burden of the condition, as longitudinal studies have 
shown that people may qualify for a diagnosis at one wave but not another (Zissimopoulos et al., 
2018), further complicated by practice effects, even in people with mild to more severe 
pathology (Gross et al., 2018).  
Medicare Claims Data  
One final method for establishing prevalence estimates features Medicare claims data, 
which is a valuable epidemiologic tool, as they cover virtually all adults over the age of 65 in the 
US, including those in both institutional and noninstitutional settings. However, these, too, show 
differences in estimates depending on disease definition. For example, using a 20% random 
sample of Medicare fee-for-service beneficiaries throughout the country, Koller and Bynum 
(2015) estimated that 8.5% of adults above the age of 65 have a dementia subtype. More 
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recently, Goodman and colleagues (2017) looked at all Medicare beneficiaries and found 14.4% 
have a dementia subtype listed in their record. Here again, variations in methods (i.e., ICD-9 
coding) yield substantially different dementia prevalence estimates. Moreover, some past 
research has found that Medicare claims may undercount the true prevalence of dementia as 
compared to more in-depth neuropsychological testing. In a study linking Aging, Demographics, 
and Memory Study participants to their Medicare claims data, 14.5% of individuals were 
classified as having dementia based upon neuropsychological assessment but did not have a 
dementia diagnosis code within their Medicare claims record (Taylor et al., 2009). 
Estimates of SCD   
Estimates of SCD across studies show even wider variability than those for dementia, 
likely because there is no standardized approach to measuring it. For example, a recent review 
of 16 international population-based cohort studies found the prevalence of SCD ranged from 
6.1% to 52.7% based on self-reports within adults over age 60 (Röhr et al., 2020), with similarly 
wide estimates in US samples (van Harten et al., 2018). Moreover, an analysis by the Subjective 
Cognitive Decline Initiative found little consistency in SCD items used across 19 international 
studies, with 73% of items created uniquely for each individual study (Rabin et al., 2015). There 
have been recent calls to harmonize measures, and researchers have recently begun to study the 
impact of individual items used to create estimates, with wide methodology and ways of probing 
likely causing this range.  
While some nationally representative studies make use of cognitive batteries to assess the 
prevalence of dementia and SCD, more common are self-report items embedded in each study. 
Estimates garnered from self-report items often complement objective assessment, and they have 
been shown in past research to produce prevalence estimates that are comparable to more in-
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depth case ascertainment (Bernstein & Remsburg, 2007; Griffith et al., 2020; Mulvale, 2015). 
However, just as objective assessments vary from study to study, so too do self-report 
items. Next, we review characteristics of these items that could contribute to differences in 
prevalence estimates.  
Variability in Item Construction   
Although simple items in national surveys appear to be designed to ask respondents about 
the same constructs (i.e., the presence of dementia and SCD), inconsistencies in terminology and 
timeframe could contribute to different prevalence estimates.  
Terminology  
One source of variability across national studies is their use of different terminology. For 
example, the Health and Retirement Study (HRS) asks if an individual has ever been diagnosed 
by their doctor with “dementia, senility, or any other serious memory impairment,” while the 
PSID asks a more general question about a doctor’s diagnosis of “[p]ermanent loss of memory or 
loss of mental ability.” Other studies use items that ask about specific conditions, such as the 
NSHAP, which asks about “Alzheimer’s disease” or “vascular dementia,” while the BRFSS and 
NHANES simply discuss “conditions” which cause “problems with remembering.” Even greater 
variation is found across SCD items, which ask respondents, in various ways, about basic 
cognitive complaints, attention difficulties, difficulties with language, or memory concerns 
(Abduulrab et al., 2008; Jessen et al., 2014). It is possible that items that use less precise 
terminology (e.g., “memory loss”) may yield higher prevalence estimates than items that use 






Another facet of items that may lead to variable estimates has to do with the timeframe 
referenced. An item from the Midlife in the United States Study (MIDUS) study asks 
participants to rate their memory over the past five years, while one from the HRS uses a 2-
year timeframe, and another in the NHATS only uses a single year. Past research on emotional 
experiences found that when a timeframe of “last week” was used, participants inferred that 
researchers were more interested in minor, more frequent events (i.e., minor experiences of 
anger), whereas when the timeframe was “last year,” participants inferred that researchers were 
more interested in major, infrequent events (i.e., episodes of severe anger), leading to different 
reports of the severity and frequency of symptoms (Winkielman et al., 1998). Extrapolating to 
items about SCD, when presented with a longer timeframe, respondents might only endorse 
major changes in cognitive functioning, overlooking minor changes they would identify with a 
shorter timeframe. The “peak-end rule” suggests that longer timeframes yield higher rates of 
endorsement, as individuals will have a greater probability of experiencing a significant change 
over that longer period (Walentynowicz et al., 2018). Conceivably, individuals will have had a 
greater likelihood of cognitive decline when a longer timeframe is presented, leading them to 
endorse more frequent and more severe SCD as the timeframe is longer.  
Current Study  
This review has pointed out several reasons why obtaining estimates of the prevalence of 
dementia and SCD is difficult in survey studies, and potential reasons why there are disparate 
findings. Though calls have been made to harmonize items across studies (Rabin et al., 2015), 
most studies continue to use different items in their most recent waves, which will continue to 
lead to different estimates. To our knowledge, no previous study has undertaken a systematic 
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evaluation of methodological variation in dementia and SCD items across national studies and its 
association with prevalence estimates. Therefore, the purpose of this study is to analyze the 
dementia and SCD items in eight nationally representative population-based surveys. This study 
has two specific aims.  
First, we will examine the concordance of dementia prevalence estimates for reported 
dementia and SCD across national studies. Based on previous research on other health 
conditions, we expect to find significant variability across studies. Second, we will investigate 
whether differences in prevalence estimates are related to differences in item terminology and 
timeframe. For dementia, we hypothesize that items that incorporate more broad terminology 
will receive higher endorsement. For SCD, we hypothesize that items with a longer timeframe 
will yield higher prevalence estimates.  
Methods 
Data Sources  
We identified eight U.S.-based cross-sectional and longitudinal studies with publicly 
available datasets that had items related to dementia and SCD (see Table 1). In selecting studies, 
we followed a similar strategy to Giovanetti and Wolf (2010). Notably, studies needed to employ 
an observational design, probability-based sampling, and generate nationally representative 
estimates through weighting. To control for potential time-of-measurement effects, we analyzed 
data from 2013 – 2014 for most surveys, apart from the NSHAP, whose next closest wave was in 
2015-2016. We reviewed each study’s fieldwork documentation and questionnaires for 
dementia- and SCD-related items (see Measures) and extracted those with parallel content in at 
least one other survey. We analyzed data for all individuals age 65 and above, from both self- 




Prevalence of Reported Dementia  
We defined the prevalence of dementia as indicated by an affirmative response regarding 
a “condition” that impacts “remembering,” or through a self or proxy reported diagnosis made by 
a doctor (see Table 2). Several of the longitudinal studies (i.e., HRS, NHATS, NSHAP, PSID) 
preload data about whether a respondent reported a dementia diagnosis in a previous wave, 
which is then verified with the respondent. Both previous and current reporting of dementia 
indicated a positive case for our analysis. However, if a participant disputed a previous 
diagnosis, they were treated as a negative case. The HRS was the only study that contained two 
questions related to dementia, one asking specifically about Alzheimer’s disease (AD) and one 
about other more global indicators of memory loss (such as “senility”).  Respondents were first 
asked about AD, and if a positive response was given, the following question on dementia was 
not asked. We collapsed these items to form one variable indicating the presence of dementia to 
allow for overall comparisons across studies. 
Prevalence of Self-Reported Subjective cognitive decline  
We identified similar self-reported items within four datasets that focused on perceptions 
of one’s own cognitive functioning over time (see Table 3). As discussed in the literature review, 
there was heterogeneity in SCD items, creating complications for comparisons, though we used 
items with the most similar content. Since there were several different approaches taken across 
studies, we broke items into two separate categories, those focusing on changes within memory 
ability over a longer period, and those focused on frequency of memory problems over a 
narrower period. Because response scaling options related to the severity of memory loss varied, 
we collapsed items. Participants who indicated that their memory changed in a negative direction 
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(e.g., responses including” worse”) were considered to have SCD. Items related to frequency 
were dichotomized, with greater than normal frequency considered an endorsement of SCD 
(following Taylor et al., 2018). 
Demographics 
 Age, sex, race/ethnicity, and educational level were reported in each dataset. To allow for 
comparability across each dataset, we grouped respondents into three age categories (65-74, 75-
84, 85+). Sex was treated as a binary variable (male, female). We grouped race/ethnicity into 
three categories (non-Hispanic white, non-Hispanic black, and other races), and education into 
three levels (less than high school, high school, and some college and above). 
Data Analysis  
Univariate and descriptive statistics were conducted using analytic weights provided 
within each dataset to generate estimates for a nationally representative sample. All missing data, 
including responses such as “Don’t know” or “Refused,” were excluded from our analyses. We 
prepared a Complex Sample Analysis Plan and calculated prevalence estimates proportions, 
standard errors, and 95% confidence intervals in SPSS (Version 27.0). We then ran pairwise 
comparisons of each survey using a 2-tailed z-test, which is consistent with the method used in 
previous studies that have made comparisons across national surveys (Fahimi et al., 2008; Hsia 
et al., 2020). Z-test analyses were conducted in R (R Core Team, 2019). For prevalence of 
dementia, we assumed a null hypothesis of equality of proportion estimates across surveys and 
used a nominal α of 0.05 adjusted for multiple comparisons to determine statistically significant 
differences across surveys. For SCD, we used a one-tailed z-test to determine whether longer 




Reported Prevalence of Dementia  
Table 4 shows the weighted point estimates, standard errors, absolute differences, z-
values, and p-values for comparisons of self-reported dementia prevalence across studies. 
Overall, dementia prevalence within the seven studies ranged considerably from 2.7% - 9.9%. 
Absolute differences between studies range from 0.04% to 7.18% (mean absolute difference = 
3.61%, SD = 2.23%). Differences were statistically significant across 17 of the 21 Bonferroni-
corrected comparisons. Of note, the prevalence in the BRFSS and NHANES, which used the 
same item, were comparable (z = 0.051, p = 0.959), but significantly higher than the prevalence 
estimates in every other survey. Furthermore, prevalence estimates from the NHIS and NSHAP, 
the studies with the lowest estimates, did not differ from one another. 
 Table 5 displays reported dementia prevalence across demographic characteristics (age, 
sex, race, and education) for persons over age 65 for each study. Because of the limitations 
associated with conducting multiple statistical tests, we did not calculate differences across 
studies for these demographic characteristics, but we have included them here as reference for 
future investigators. Examining trends, here, too, prevalence estimates appear to vary widely, 
and across all studies, dementia prevalence was higher with later age and lower levels of 
education. Most studies showed similar trends, with higher rates in females and individuals who 
did not identity as white.  
Reported Prevalence of SCD  
Table 6 shows the weighted point estimates, standard errors, absolute differences, z-
values, and p-values for comparisons of reported SCD across studies whose items referenced 
changes in memory ability over different times frames. Nearly half (46.56%; 95% CI = 42.11 – 
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51.07%) of the respondents reported SCD in the MIDUS, whose item used a 5-year time 
window. Nearly one-quarter (24.34%; 95% CI = 23.41 - 25.29%) reported SCD in the HRS, 
whose item used a 2-year time window. One-seventh (13.01%; 95% CI = 11.83% - 14.29%) 
reported SCD in the NHATS, with its one-year window. The largest absolute difference was 
between the MIDUS and the NHATS (31.23%). Consistent with our hypotheses and as evident 
in Table 6, one-tailed z-tests showed higher estimate across the longer time frames.   
We further assessed two items that framed self-reported SCD in terms of frequency. On 
the NHANES measure that asked about SCD experiences only in the past 7 days, 5.64% (95% CI 
= 4.14 - 7.64%) reported frequent problems with remembering. However, on the NHATS 
measure that focused on the past month, 8.74% (95% CI = 7.75 – 9.85%) indicated frequent 
problems with memory. Consistent with our earlier findings, higher rates were evident on the 
item using a longer time frame, z = 3.21, p < 0.001.  
Discussion 
In this study, we compare prevalence rates of reported dementia and SCD across eight 
prominent national surveys. Prevalence estimates ranged considerably, with a range of 2.7% - 
9.9% for dementia and 5.6% - 46.6% for SCD. These prevalence estimates are used for a variety 
of purposes in research, practice, and policy, and the range we identified across studies has 
important implications for how the burden of disease is considered. For example, if we 
extrapolate our dementia percentages based on the 2010 US census, the prevalence across studies 
would differ by anywhere from 1,080,040 to 3,973,580 cases. Our results point to the need for 
caution when utilizing survey-based prevalence estimates and the need for consumers of these 
estimates to be knowledgeable about their source.  
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Although there might be several explanations for differences across studies, we highlight 
notably different terminology to assess for the prevalence of dementia and SCD. Among the 
dementia items analyzed, some studies inquire about specific types of dementia, while others use 
more global terminology associated with cognition. For example, the PSID asks respondents 
about “permanent loss of memory or mental ability.” This phrase might cover a variety of 
different pathologies (e.g., stroke, multiple sclerosis, autism spectrum disorder, dementia 
subtypes), thereby leading to a relatively high estimate because it encompasses several 
conditions. The BRFSS and NHANES, two of the nation’s largest cross-sectional health studies, 
are similarly broad, with both assessing for a “physical, mental, or emotional condition” that 
inhibits “thinking, memory, or concentration.” Again, considering this kind of broad description, 
other conditions such as depression or attention-deficit/hyperactivity disorder could lead to 
higher endorsement rates. And although similarly broad, note the difference in wording from the 
PSID. These premier studies also use a double-barreled question, which may lead to less valid 
prevalence estimates (Menold, 2020). Across all our analyses, prevalence rates were significantly 
higher in studies that used the most general terminology. That fact alone does not necessarily call 
into the question of the prevalence estimates, but it does highlight the need for readers of these 
prevalence estimates to pay close attention to how they were obtained. 
The NHIS is another study whose question structure and branching logic could have an 
impact on dementia estimates. The NHIS uses a two-part structure to inquire about dementia.  
First, participants must affirm that they are limited on an activity of daily living, instrumental 
activity of daily living, or problems associated with memory. Second, only those who endorse a 
limitation are presented with a separate, open-ended question about the diseases or conditions 
that cause the limitation. Conditions associated with age-related memory loss or impairment 
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(such as Alzheimer’s disease) are then coded by the interviewer under the umbrella term 
“senility.” This method has the potential to overlook respondents in the early stages of a 
neurocognitive disorder in which function is unimpaired. The method also relies on reliable 
coding by the interviewer, aggregating causes into a very diffuse and technically inaccurate 
category (i.e., “senility”). The methodological idiosyncrasies of the NHIS argue for ample 
caution when comparing estimates from this study.    
Our item analysis also revealed that many of the studies rely on just one item, and that 
one item groups many different types of dementia. This stands in contrast to the precision used to 
establish the prevalence of other health conditions. For example, both the BRFSS and NSHAP 
inquire about cancer generally and then probe for specific types. A similar method would be 
recommended for dementia subtypes, to learn more about the burden of these lesser common 
conditions.  
We identified similar methodological variability regarding SCD items, which could 
explain similar differences in prevalence estimates. Time frames vary widely across studies, with 
items inquiring about experiences of cognitive impairment in the past week or over as many as 
the past five years. Consequently, prevalence estimates vary significantly too, from about one in 
20 when thinking about only the past week, to just under half of older adults when the time 
frame is set at five years. As Jessen and colleagues (2014) suggest, the time frame of onset for 
SCD can have predictive utility for more severe cognitive decline, but only when it is kept short. 
Longer time frames have the potential to overestimate the burden of SCD and lack clinical 
utility, as only a small minority will go on to develop dementia. Moreover, response options 
differ as well. The severity of SCD is rated on a three-point Likert-type scale in the HRS but a 
five-point Likert-type scale in the MIDUS and NHATS, making comparisons unwieldy.   
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Another factor that could contribute to variation in prevalence estimates only became 
apparent as we discovered some of the arcane and obscure details regarding sampling methods 
across studies. Although all these studies purport to be representative of the community-based 
US population, in many cases individuals with cognitive impairment are excluded from taking 
the survey during recruitment, which could itself lead to skewed population prevalence 
estimates. In the NSHAP, participants were excluded if the interviewer “felt the participant had 
inadequate cognitive ability to complete the survey questions,” (Vasilopoulos et al., 2014, p. 
S161) which could obviously deflate prevalence estimates. However, these sampling details are 
not described in study documentation (i.e., field reports, technical files) that we reviewed, but 
instead were revealed in a 2014 article (Vasilopoulos et al., 2014) that we uncovered after 
completing our analyses and exploring potential alternative reasons for this low estimate. A 
similar exclusion strategy is used in the BRFSS, although here again, this information is not 
available in the publicly available study documentation and was glossed over during a training 
webinar we attended. The video mentions in one sentence that interviewers are granted the 
latitude to terminate their telephone conversation should they feel they are obtaining “unreliable 
data” from someone with a suspected cognitive impairment (Taylor, 2021). Here again, we draw 
reader’s attention to these methodological variations so that prevalence estimates can be placed 
into appropriate context.  
In addition to the factors outlined above, we should also mention the vulnerabilities 
inherent in self- and proxy-reports of dementia and SCD. Self and proxy reports rely on 
sufficient insight to identify impairment, yet awareness may be limited, and furthermore, 
diagnoses of these conditions are lacking. For example, one study looking at 425 community-
dwelling older adults admitted to a post-acute care unit found that nearly three-quarters (70.8%) 
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reached dementia diagnostic criteria but were not diagnosed (Ferretti et al., 2010). More recently, 
using a subsample of the NHATS, Amjad and colleagues (2018) found that 39.5% of older adults 
with probable dementia as determined by the study’s assessment criteria did not have a 
diagnosis, and 19.2% had a diagnosis that they were unaware of. Self and proxy reports also rely 
on a willingness to disclose this information. Stigma and shame may inhibit acknowledging the 
presence of a dementia diagnosis or memory loss (Milne, 2010), and underdiagnosis and 
unawareness, especially in community samples, can also play a role (Lang et al., 2017).   
Although we identified significant differences in prevalence estimates across national 
studies and several factors that could contribute to those differences, our own approach has its 
limitations as well. While we were methodical in reviewing hundreds of pages of study 
documentation and contacted study investigators to inquire about sampling methods, it is 
possible that we overlooked sampling details, and we did not get a direct response from every 
study group. In addition, some studies incorporate proxy reports (HRS, NHATS) but others do 
not, introducing another source of methodological variability. Previous research has identified 
discordance between respondent and proxy reports (Howland et al., 2017), though proxies may 
be able to provide more accurate data than individuals with more severe cognitive impairments. 
Lastly, estimation of prevalence within survey data is always subject to random error, and the 
differences we identified between surveys are similarly influenced by this potential error. 
In conclusion, while calls have been made to harmonize SCD items across studies 
(Rabins et al., 2015), large-scale studies continue to use variable methods to ascertain reported 
prevalence estimates for dementia and SCD. Our study provides additional evidence of the need 
to establish harmonized terminology and methods. Given that dementia is highly stigmatized, 
underdiagnosed in some groups, loosely diagnosed in some settings, and vulnerable to reporting 
16 
 
bias, items that inquire about a previous dementia diagnosis may be least useful in establishing 
prevalence. However, if these items remain on surveys, we recommend unpacking them to learn 
more about specific subtypes. In addition, we recommend two dichotomous measures on 
significant changes within memory and thinking that may be useful for future studies. Note that 
we call for these to be included as separate measures, and for an end to the double-barreled 
approach to questioning. Lastly, we recommend that studies keep time frames short (past week, 
past month) to reduce retrospective bias. Harmonizing items across studies may better harness 
the strengths of national studies identifying the prevalence cognitive limitations and the true 
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Notes: In household interviews, a single family member from each household answers questions 




Items About Dementia 
 Survey  Variable Name   Item   
BRFSS  DECIDE Because of a physical, mental, or emotional condition, do you have 
serious difficulty concentrating, remembering, or making decisions?  
HRS  OC272 Has a doctor ever told you that you have Alzheimer’s Disease?   
OC273 Has a doctor ever told you that you have dementia, senility or any 
other serious memory impairment?   
NHANES  DLQ040 Because of a physical, mental, or emotional condition, {do you/does 
he/does she} have serious difficulty concentrating, remembering, or 
making decisions?  
NHATS  hc4disescn9 Since the time of the last interview, has a doctor told you/SP that 
you/SP had dementia or Alzheimer’s Disease?   
NHIS  LAHCA16 What condition or health problem causes you to have difficulty with 
{names of up to 3 specified activities/these activities}  
NSHAP  CONDITNS_83 Has a doctor ever told you that you have dementia, including 
Alzheimer's disease, vascular dementia, mixed dementia, or Mild 
Cognitive Impairment?   
PSID  ER55293 
ER56409 
(Has a doctor or other health professional EVER told [you / [HEAD / 
SP/WIFE]] that [you / he / she] had …) Permanent loss of memory or 
loss of mental ability?   
Notes: Affirmative (“Yes”) responses to these items, including if the condition was previously 
mentioned in earlier years, indicated presence of dementia. For the NHIS item, presence of 
dementia was indicated through a response of “senility.”   
BRFSS = Behavioral Risk Factor Surveillance System; HRS = Health and Retirement Study; 
NHANES = National Health and Nutrition Examination Survey; NHATS = National Health and 
Aging Trends Survey; NHIS = National Health Interview Survey; NSHAP = National Social 
Health and Aging Project; PSID = Panel Study of Income Dynamics. SP = Sample Person.    







Items About SCD 
 
Severity Point of Reference  
Study  Variable Name  Item  Response Options  
HRS  D102  Compared to [[Previous Month], two 
years ago], would you say your/SP’s 
memory is better now, about the  
same, or worse now than it was 
then?   
  
1. Better   
2. Same   
3. Worse   
  
MIDUS  C1SA6E  Compared to five years ago, how 
would you rate yourself today on    
1. Improved a lot   
2. Improved a little   
3.   Stayed the same   
4. Gotten a little worse   
5. Gotten a lot worse   
NHATS  cg4memcom1yr  Compared to 1 year ago, would 
you say your memory is much better 
now, better now, about the same, 
worse now, or much worse now than  
it was then?   
  
1. Much better   
2. Better   
3. Same   
4. Worse   
5. Much worse   
Frequency Point of Reference  
NHANES  MCQ380  Over the past 7 days, how often have 
you/they? had trouble remembering 
where you/they put things, like 
your/their keys or your/their wallet?  
1. Never  
2. About once  
3. Two or three times  
4. Nearly every day  
5. Several times a day  
NHATS  cg4ofmemprob  In the last month, how often did 
memory problems interfere with 
your daily activities? Would you say 
every day, most days, some days, 
rarely, or never?   
1. Every day (7 days a week)   
2. Most days (5-6 days a week)   
3. Somedays (2-4 days a week)   
4. Rarely (once a week or less)   
5. Never   
Notes: HRS = Health and Retirement Study; MIDUS = Midlife in the United States Study; 
NHATS = National Health and Aging Trends Survey; NHANES = National Health and Nutrition 









Pairwise Comparisons of Proportions of Older Adults with Reported Dementia    
Study   BRFSS   
% (SE)   
NHANES   
% (SE)   
NHATS   
% (SE)   
PSID   
% (SE)   
HRS   
% (SE)   
NSHAP   
% (SE)   
NHIS   
% (SE)   
  9.86 
(0.17)   
9.82 
(0.67)   
7.27 
(0.42)   
6.30 
(0.74)   
4.10 
(0.20)   
3.26 
(0.48)   
2.68 
(0.15)   
NHANES   0.035   
0.051   
0.959   
             






           









         












       















     



















Notes: Table figures are rounded to the thousandths place; calculations were not rounded. In 
order from top to bottom, each cell contains absolute difference, z-value, and p-
value. Bonferroni-corrected significant pairwise differences are indicated with bold text. 
BRFSS = Behavioral Risk Factor Surveillance System; NHANES = National Health and 
Nutrition Examination Survey; NHATS = National Health and Aging Trends Survey; PSID = 
Panel Study of Income Dynamics; HRS = Health and Retirement Study; NSHAP = National 









% (95% CI)  
NHANES  
% (95% CI )  
NHATS  
% (95% CI )  
PSID  
% (95% CI )  
HRS  
% (95% CI )  
NSHAP  
% (95% CI )  
NHIS  
% (95% CI )  
Overall  9.9 (9.5, 10.2)  9.8 (8.5, 11.3)  7.3 (6.5, 8.2)  6.3 (5.0, 8.0)  4.1 (3.7, 4.5)  3.3 (2.4, 4.4)  2.7 (2.4, 3.0)  
     Age 65-74  9.1 (8.7, 9.6)  8.2 (6.6, 10.2)  2.2 (1.6, 3.0)  2.7 (1.6, 4.5)  1.7 (1.4, 2.2)  2.1 (1.3, 3.4)  0.9 (0.6, 1.1)  
     Age 75-84  10.8 (10.3, 11.4)  12.3 (10.0, 15.0)  7.6 (6.3, 9.1)  5.8 (3.9, 8.5)  5.2 (4.5, 6.0)  4.1 (2.4, 6.9)  3.7 (3.1, 4.5)  
     Age 85+  NAa  NAa  18.1 (15.6, 20.9)  22.2 (16.8, 28.6)  12.7 (11.0, 14.6)  8.6 (5.5, 13.3)  8.9 (7.4, 10.7)  
Sex                
     Male  9.2 (8.8, 9.7)  7.9 (5.5, 11.4)  6.6 (5.5, 7.8)  4.8 (3.5, 6.6)  4.2 (3.7, 4.7)  3.4 (2.1, 5.3)  2.6 (2.1, 3.1)  
     Female  10.4 (9.9, 10.8)  11.3 (9.5, 13.4)  7.8 (6.8, 9.0)  7.5 (5.6, 10.0)  4.0 (3.5, 4.6)  3.2 (2.2, 4.6)  2.8 (2.4, 3.2)  
Race                
     White  8.7 (8.4, 8.9)  9.4 (8.0, 11.1)  7.0 (6.1, 8.0)  6.2 (4.8, 8.0)  3.8 (3.4, 4.3)  3.4 (2.5, 4.7)  2.5 (2.2, 2.9)  
     Black  13.7 (12.4, 15.1)  8.6 (5.3, 13.7)  8.6 (6.9, 10.8)  7.4 (4.4, 12.3)  6.6 (5.1, 8.5)  3.0 (1.4, 6.0)  4.0 (3.1, 5.1)  
     Other  14.1 (12.5, 15.9)  13.0 (11.2, 15.1)  8.3 (5.8, 11.7)  NAb  4.6 (2.7, 7.8)  2.1 (1.0, 4.5)  3.4 (2.3, 5.1)  
Education                
     Less than     
I   HS     
18.8 (17.6, 20.1)  15.9 (10.2, 23.9)  12.2 (10.2, 14.6)  10.5 (6.5, 16.4)  6.7 (5.6, 8.0)  4.2 (2.2, 7.6)  4.7 (3.8, 5.7)  
     HS  10.0 (9.5, 10.5)  9.5 (6.4, 14.0)  7.3 (5.9, 8.9)  7.4 (5.1, 10.7)  3.9 (3.1, 4.8)  2.4 (1.2, 4.8)  2.6 (2.2, 3.1)  
     College  6.9 (6.5, 7.3)  7.9 (6.1, 10.1)  5.2 (4.2, 6.5)  4.5 (3.2, 6.5)  3.2 (2.9, 3.7)  3.4 (2.5, 4.7)  1.9 (1.6, 2.3)  
Notes: Percentages and confidence intervals are weighted. 
BRFSS = Behavioral Risk Factor Surveillance System; NHANES = National Health and Nutrition Examination Survey; NHATS = National Health and 
Aging Trends Survey; PSID = Panel Study of Income Dynamics; HRS = Health and Retirement Study; NSHAP = National Social Health and Aging Project; 
NHIS = National Health Interview Survey. HS = High school. CI = Confidence Intervals.  
a Data on ages above 80 are not publicly available for BRFSS or NHANES; for those surveys this category represented age 75 + years.  




Pairwise Comparisons of Proportions of Older Adults with Reported SCD   
Study  MIDUS  
% (SE)  
HRS  
% (SE)  
NHATS  
% (SE)   
46.56 (2.29)  24.34 (0.47)  13.01 (0.61)  
HRS  22.219  
9.51  
<0.001  
    







Notes: Table figures are rounded to the thousandths place; calculations were not rounded. In 
order from top to bottom, each cell contains absolute difference, z-value, and p-
value. Bonferroni-corrected significant pairwise differences are indicated with bold text. 
MIDUS = Midlife in the United States Study; HRS = Health and Retirement Survey; NHATS = 
National Health and Aging Trends Survey. SE = Standard Error. 
